Aaron Cowen’s Quest Diagnostics DGX Stock Holding History

Aaron Cowen’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-357,835	Closed	-$40.8M	–	101
2020 Q2	$40.8M	Buy	+357,835	New	+$38M	0.88%	40

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $7.03B AUM 11.68% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Aaron Cowen's DGX Position: Q3 2020 in Review

Aaron Cowen sold out of Quest Diagnostics (DGX) in Q3 2020, closing a stake of 357,835 shares — an estimated $40.8M sold.

Aaron Cowen first reported a position in DGX in Q2 2020 and held it in 1 quarter. The position peaked at $40.8M in Q2 2020. 758 funds tracked by Wall St. Rank hold DGX as of Q3 2020.

Aaron Cowen reported no remaining Quest Diagnostics position as of Q3 2020 after selling out during the quarter.
Aaron Cowen sold 357,835 Quest Diagnostics shares in Q3 2020, an estimated $40.8M.
Aaron Cowen first reported a position in Quest Diagnostics in Q2 2020 and held it in 1 quarter.
Aaron Cowen's Quest Diagnostics position peaked at $40.8M in Q2 2020.
758 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2020.

Based on Suvretta Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.